Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative

Biol Blood Marrow Transplant. 2013 Jan;19(1):4-11. doi: 10.1016/j.bbmt.2012.10.005. Epub 2012 Oct 15.

Abstract

The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. "Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative" used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Congresses as Topic
  • Delivery of Health Care* / economics
  • Delivery of Health Care* / methods
  • Delivery of Health Care* / organization & administration
  • Female
  • Guideline Adherence* / economics
  • Guideline Adherence* / organization & administration
  • Guideline Adherence* / standards
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Societies, Medical*
  • Tissue Donors*